Fen-Phen Malpractice Awards Denied By Texas High Court

Law360, Houston (December 13, 2013, 7:42 PM EST) -- The Texas Supreme Court refused Friday to reinstate a jury’s verdict that resulted in awards exceeding $10 million against a Houston attorney who allegedly overcharged clients in litigation against a Pfizer Inc. unit over the diet drug fen-phen.

The high court denied a petition for review pushed by a group of George Fleming’s former clients who were seeking to overturn a decision by the Fourteenth District Court of Appeals that testimony of a legal ethics expert in a test case “crossed the border of admissibility."...
To view the full article, register now.